- Oncology >
- Oncology >
- Titanium implantable port >
- B Braun
B Braun titanium implantable ports
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}

... sampling or transfusion. The port has an epoxy body with a titanium chamber and is high pressure resistant up to 325 PSI (22,4 bar). Special Features - Compact port design with enlarged ...
Aesculap®

... CT" marking (except for the US market) which indicates power injectability of the port on x-ray - Compact port design with enlarged puncture area in relation to the port housing size - ...
Aesculap®

Celsite® Discreet Venous access ports with unique design for enhanced port stability and better cosmetic results Celsite® Discreet Access Port Systems are indicated for any condition ...
Aesculap®

... Special Features - Compact port design with large puncture area in relation to the port housing size - Available with radiopaque "CT" marking (except for the US market) which indicates power injectability ...
Aesculap®

Celsite® Double Specialized venous access ports with two separated port chambers for simultaneous infusion Celsite® Double Access Port Systems are indicated for any condition ...
Aesculap®

... therapy (surgical implantation technique) Celsite® Arterial Port Systems are indicated for arterial applications and permit loco-regional chemotherapy directly targeting tumours. The port is implanted ...
Aesculap®

... is secured with the radiopaque titanium connection ring - Radiopaque 15F silicone catheter with multiple perforations ensures optimal diffusion - Compact port design with enlarged puncture area in ...
Aesculap®

... infection risk and holds the catheter securely in place - Compact port design with enlarged puncture area in relation to the port housing size - Connection is secured with the radiopaque titanium ...
Aesculap®
Your suggestions for improvement:
Please specify:
Help us improve:
remaining